The State of Texas Top Legal Officer Files Lawsuit Against Tylenol Manufacturers Concerning Autism Assertions
The top legal official in Texas Paxton is filing a lawsuit against the makers of Tylenol, claiming the corporations withheld potential risks that the drug presented to children's cognitive development.
The lawsuit arrives a month after Former President Trump advocated an unsubstantiated connection between using Tylenol - alternatively called paracetamol - while pregnant and autism in offspring.
The attorney general is suing Johnson & Johnson, which formerly manufactured the drug, the sole analgesic approved for pregnant women, and Kenvue, which presently makes it.
In a official comment, he claimed they "misled consumers by profiting off of suffering and pushing pills regardless of the potential hazards."
Kenvue states there is no credible evidence connecting acetaminophen to autism spectrum disorder.
"These companies misled for generations, intentionally threatening numerous people to line their pockets," the attorney general, from the Republican party, declared.
The company stated officially that it was "very worried by the spread of false claims on the security of acetaminophen and the likely effects that could have on the health of US mothers and children."
On its official site, Kenvue also mentioned it had "continuously evaluated the applicable studies and there is insufficient valid information that demonstrates a verified association between consuming acetaminophen and autism spectrum disorder."
Groups speaking for medical professionals and healthcare providers share this view.
ACOG has said paracetamol - the key substance in acetaminophen - is a restricted selection for women during pregnancy to treat discomfort and fever, which can present serious health risks if ignored.
"In multiple decades of investigation on the consumption of paracetamol in pregnancy, zero credible investigations has successfully concluded that the use of paracetamol in any trimester of gestation causes brain development issues in young ones," the association said.
The lawsuit cites recent announcements from the Trump administration in claiming the drug is allegedly unsafe.
Last month, the former president generated worry from public health officials when he instructed women during pregnancy to "struggle intensely" not to take acetaminophen when ill.
The FDA then issued a notice that medical professionals should think about restricting the consumption of Tylenol, while also declaring that "a direct connection" between the drug and autism in children has remains unverified.
The Health Department head Robert F Kennedy Jr, who supervises the FDA, had promised in spring to initiate "comprehensive study program" that would determine the source of autism in a matter of months.
But experts cautioned that discovering a sole reason of autism - believed by scientists to be the consequence of a intricate combination of genetic and surrounding conditions - would be difficult.
Autism spectrum disorder is a type of permanent neurological difference and impairment that influences how people experience and interact with the world, and is diagnosed using physician assessments.
In his lawsuit, the attorney general - a Trump ally who is campaigning for the Senate - alleges the manufacturer and J&J "deliberately disregarded and attempted to silence the research" around paracetamol and autism.
The case aims to force the corporations "remove any commercial messaging" that claims Tylenol is reliable for expectant mothers.
The court case mirrors the complaints of a assembly of mothers and fathers of minors with autism spectrum disorder and attention deficit hyperactivity disorder who sued the makers of Tylenol in recently.
Judicial authorities threw out the legal action, stating investigations from the plaintiffs' authorities was lacking definitive proof.